Pharmaceutical Business Review
Return to: PBR Home
Search Results:
1-15 of 56203 results
BenevolentAI buys drug discovery and development facility in Cambridge, UK
BenevolentAI has acquired an advanced drug discovery and development facility on the Babraham Research Campus in Cambridge, UK, for an undisclosed sum.
Drug Research > Drug Discovery & Development > News
New collaborative project to develop Zika virus vaccine for pregnant women
A new collaborative project has been launched to develop a Zika virus vaccine that is suitable for use in pregnancy.
Drug Research > Drug Discovery & Development > News
Kite, Sangamo form $3bn cancer cell therapy collaboration
By PBR Staff Writer
Gilead Sciences’ subsidiary Kite has agreed to use Sangamo Therapeutics’ zinc finger nuclease (ZFN) technology platform to develop cancer treatments in a collaboration deal worth over $3bn.
Drug Research > Drug Discovery & Development > News
Emulate, Roche partner to apply organ-chips to drug efficacy and safety
By PBR Staff Writer
Scientists from Emulate and Roche have partnered to use Organ-Chips for testing of efficacy and safety of new antibody therapeutics and combination therapies.
Drug Research > Drug Discovery & Development > News
ATUM, Just Biotherapeutics collaborate to speed up drug discovery
ATUM has signed a patent licensing agreement, which gives Just Biotherapeutics access to its Leap-In cell line development tools.
Drug Research > Drug Discovery & Development > News
FDA accepts Acorda’s NDA for orally inhaled levodopa therapy Inbrija
The US Food and Drug Administration (FDA) has accepted for filing Acorda Therapeutics' new drug application (NDA) for Inbrija (levodopa inhalation powder).
Regulatory Affairs > News
Merck to buy Viralytics to boost immuno-oncology pipeline
By PBR Staff Writer
Merck has agreed to acquire Australian biotechnology firm Viralytics, which is focused on developing oncolytic immunotherapy treatments for cancers, for about A$502m ($394m).
Drug Research > Drug Discovery & Development > News
Tetraphase, Everest sign licensing deal for cIAI drug eravacycline in China
Tetraphase Pharmaceuticals has signed an exclusive licensing agreement with Everest Medicines to develop and commercialize complicated intra-abdominal infections (cIAI) drug eravacycline in mainland China, Taiwan, Hong Kong, Macau, South Korea, and Singapore.
Drug Research > Drug Discovery & Development > News
Orano Med, RadioMedix recruit first patients in AlphaMedix phase 1 clinical trial
Orano Med and RadioMedix have recruited first three patients in the AlphaMedix phase 1 clinical trial.
Contract Research & Services > Clinical Trials > News
Mylan bags FDA’s tentative approval for fixed-dose HIV combo therapy
By PBR Staff Writer
Mylan has secured tentative approval from the US Food and Drug Administration (FDA) for its fixed-dose HIV combination therapy Dolutegravir/Emtricitabine/Tenofovir Alafenamide (DTG/FTC/TAF 50 mg/200mg/25mg) tablets.
Regulatory Affairs > News
Sterna reports positive results in severe ulcerative colitis drug trial
By PBR Staff Writer
sterna biological has reported positive results from the SECURE study, a Phase 2a trial in patients with moderate to severe ulcerative colitis treated with its GATA-3 specific DNAzyme formulation SB012.
Contract Research & Services > Clinical Trials > News
BerGenBio completes recruitment into first stage of phase II breast cancer trial
BerGenBio has completed enrolment of the planned 28 patients into the first stage of its Phase II clinical trial evaluating its investigational oral selective AXL inhibitor bemcentinib (BGB324) in combination with the Merck’s anti-PD-1 therapy KEYTRUDA (pembrolizumab) as a potential new treatment regimen for advanced breast cancer.
Contract Research & Services > Clinical Trials > News
DanDrit Biotech acquires gene therapy company Enochian Biopharma
US-based clinical-stage company DanDrit Biotech USA has completed a previously announced acquisition of gene therapy company Enochian Biopharma.
Drug Research > Drug Discovery & Development > News
Lilly’s Taltz yields positive results in phase 3 genital psoriasis trial
By PBR Staff Writer
Eli Lilly and Company reported that Taltz (ixekizumab) in a phase 3b trial has helped patients with moderate-to-severe genital psoriasis in significantly reducing the impact of their condition on sexual activity.
Contract Research & Services > Clinical Trials > News
Novartis' Cosentyx improves skin clearance in scalp psoriasis study
By PBR Staff Writer
Novartis has announced that its Cosentyx (secukinumab) improved skin clearance in patients with scalp psoriasis in the phase III Scalp study.
Contract Research & Services > Clinical Trials > News

PBR Supplier Recommendations

Persistence Market Research: Next-Gen Industry Insights & Growth Outlook
Persistence Market Research (PMR) is essentially a third-party research firm. Our model of research is a remarkable coordinated effort of information investigation and market look into procedure to enable organizations to accomplish ideal execution. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.... Suppliers
Future Market Insights: Global Industry Outlook & Business Review
FMI, catering to clients in more than 150 different countries, is a top-ranking provider of market intelligence and research. We are headquartered in the global financial capital, London and boast of some of the finest delivery centers in the U.S. and India. Our research and consulting experts have helped a multitude of businesses to manage their individual challenges in an aggressively evolving marketplace with great precision and boldness.... Suppliers
Transparency Market Research: In-depth Analysis, Accurate Results
Transparency Market Research (TMR) is a pioneer enterprise in the field of market research. We provide a plethora of services ranging from customized research, syndicated research, and consultation services. TMR’s worldwide and regional insights on the market cover industries such as chemicals, pharmaceuticals, media and technology, consumer goods, food and beverages, among others. Every deeply researched report from TMR offers its clients a panoramic vision of the market, its prognosis and statistical forecasts, a detailed segmentation, key ongoing trends, vendor landscape along with strategic recommendations.... Suppliers
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Delivery > Suppliers
Malvern Panalytical
Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. ... Suppliers
See more

PBR White Paper Recommendations

Malvern: Understanding and minimizing polycaprolactone degradation during processing using multi-detector GPC and rheology By Malvern Panalytical
Measuring degradation related changes in molecular weight and rheology during polycaprolactone processing... White Papers How Malvern Panalytical helped GSK India optimize their manufacturing process using By Malvern Panalytical
GSK India is headquartered at Worli, Mumbai with the manufacturing unit being located at Nashik. A second manufacturing facility at Vemgal, Karnataka is due to be completed in 2018.... White Papers Malvern: High sensitivity gel permeation chromatography for agrochemical analysis By Malvern Panalytical
Exploring why Syngenta opted for an OMNISEC system... White Papers Malvern: Measuring the rheology of thermoplastic polymer melts By Malvern Panalytical
Using rotational and capillary rheometry to characterize polymer melts... White Papers Malvern: Optimizing metal powders for additive manufacturing By Malvern Panalytical
Exploring the impact of particle morphology and powder flowability.... White Papers See more
1-15 of 56203 results